C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/47 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 49/00 (2006.01) A61K 51/00 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C12N 15/12 (2006.01) G01N 33/53 (2006.01) C07K 16/18 (2006.01)
Patent
CA 2651800
The antigen recognized by the antibody produced by a deposited cell line (ATCC accession no. PTA 5411 has been shown to be a fragment of vimentin. This vimentm fragment will be useful in therapy of and screening fo cell proliferative disorders such as cancer.
L'antigène faisant l'objet de cette invention, reconnu par l'anticorps produit par une lignée cellulaire mise en dépôt (ATCC - no. de catalogue PTA 5411) s'est avéré être un fragment de vimentine. Ce fragment de vimentine est utile pour une thérapie et le dépistage de troubles liés à une prolifération cellulaire tels que le cancer.
Glassy Mark C.
Mcknight Michael E.
Mbm Intellectual Property Law Llp
Shantha West Inc.
LandOfFree
Agrm2 antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agrm2 antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agrm2 antigen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1463520